Sinaptica has developed a patented personalized form of non-invasive brain stimulation for treating Alzheimer’s, with results better than any drug. It uses a safe established TMS (Transcranial Magnetic Stimulation) technology, which is currently approved in Depression.
- Home
- 2025
- 2024
- Academy
- Being an Angel Investor
- Blockchain and Crypto
- Building Effective Teams
- Cap Tables
- Cleantech
- Corporate Governance
- Diversity, Equity and Inclusion
- Due Diligence
- Economic Outlook
- Entrepreneurs
- Exits
- Family Office Investing
- Funding Tactics
- Go To Market
- Impact Investing
- Intellectual Property
- Portfolio Diversification
- Risk Management
- Startup Valuation
- Supply Chain
- Tax Academy
- Tech and AI
- Term Sheets
- Testimonials
- Training